MAPK8 and cancer: Isorhamnetin’s ability to modulate JNK signaling underscores its role in treating cardiovascular diseases and cancer (Fig 10) [92,93].Another notable compound, 3,4-di-O-caffeoylquinic acid, exhibits strong anti-inflammatory and antioxidant properties.